ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 845 filers reported holding ISHARES TR in Q1 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,724 | -3.7% | 317 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $40,203 | -1.7% | 317 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $40,899 | -1.6% | 317 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $41,566 | +12.3% | 317 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $37,000 | 0.0% | 317 | +0.3% | 0.01% | +16.7% |
| Q2 2022 | $37,000 | -9.8% | 316 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $41,000 | -14.6% | 316 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $48,000 | -36.0% | 316 | -31.5% | 0.01% | -41.7% |
| Q3 2021 | $75,000 | +44.2% | 461 | +45.9% | 0.01% | +33.3% |
| Q2 2021 | $52,000 | +8.3% | 316 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $48,000 | -83.5% | 316 | -83.6% | 0.01% | -85.2% |
| Q4 2020 | $291,000 | +11.5% | 1,924 | -0.1% | 0.06% | 0.0% |
| Q3 2020 | $261,000 | -23.7% | 1,925 | -23.0% | 0.06% | -14.1% |
| Q2 2020 | $342,000 | +222.6% | 2,501 | +153.1% | 0.07% | +195.8% |
| Q1 2020 | $106,000 | -10.9% | 988 | +0.1% | 0.02% | -4.0% |
| Q4 2019 | $119,000 | +20.2% | 987 | -0.5% | 0.02% | +13.6% |
| Q3 2019 | $99,000 | -37.7% | 992 | -32.0% | 0.02% | -35.3% |
| Q2 2019 | $159,000 | -51.4% | 1,458 | -50.1% | 0.03% | -50.7% |
| Q1 2019 | $327,000 | +24.3% | 2,923 | +7.3% | 0.07% | +16.9% |
| Q4 2018 | $263,000 | -32.0% | 2,723 | -14.2% | 0.06% | -23.4% |
| Q3 2018 | $387,000 | +11.2% | 3,173 | +0.0% | 0.08% | +6.9% |
| Q2 2018 | $348,000 | +35.9% | 3,172 | +32.3% | 0.07% | +33.3% |
| Q1 2018 | $256,000 | -29.9% | 2,398 | -29.9% | 0.05% | -22.9% |
| Q4 2017 | $365,000 | -22.8% | 3,421 | +141.1% | 0.07% | -26.3% |
| Q3 2017 | $473,000 | +118.0% | 1,419 | +103.0% | 0.10% | +79.2% |
| Q2 2017 | $217,000 | -57.5% | 699 | -59.9% | 0.05% | -66.7% |
| Q1 2017 | $511,000 | -59.8% | 1,743 | -63.6% | 0.16% | -60.2% |
| Q4 2016 | $1,270,000 | -15.8% | 4,786 | -8.2% | 0.40% | -20.3% |
| Q3 2016 | $1,509,000 | +3.4% | 5,213 | -8.1% | 0.50% | -1.2% |
| Q2 2016 | $1,459,000 | -18.5% | 5,670 | +7.1% | 0.51% | -24.1% |
| Q1 2016 | $1,790,000 | -0.8% | 5,292 | -0.8% | 0.67% | -0.7% |
| Q4 2015 | $1,804,000 | – | 5,333 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |